BORIS LUSHNIAK was named dean of the University of Maryland School of Public Health. Lushniak will officially assume his new role on Jan. 9, 2017. Lushniak is a professor and chair of the Department of Preventive Medicine and Biostatistics, and professor of dermatology, at the F. Edward Hébert School of Medicine at Uniformed Services University...
In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL).
